Sydney Melanoma Unit
Home
About Melanoma
Care at SMU
Medical Colleagues
Research / Clinical Trials
News Room
Contact Us
Login
Community Updates
Home arrow Research / Clinical Trials arrow About Clinical Trials arrow Current Clinical Trials at SMU arrow Adjuvant Radiotherapy Trial
Adjuvant Radiotherapy Trial Print

Trial status: Open
Treatment type: Radiation therapy
Stage of disease: Stage III melanoma
Intent of treatment:Recurrence prevention

Title: A randomised clinical trial of surgery versus surgery plus adjuvant radiotherapy for regional control in patients with completely resected macroscopic nodal metastatic melanoma.

Lay Summary: This is a two-armed randomised trial in patients with nodal metastatic melanoma with no other evidence of active melanoma but who are at significant risk of regional relapse following surgical resection.

The study is designed test the hypothesis that there is a difference in regional relapse rates (recurrence) for patients undergoing complete surgical resection of macroscopic (palpable) nodal metastatic melanoma alone compared with patients receiving complete surgical resection followed by adjuvant radiotherapy.

Contacts

Professor John Thompson
Sydney Melanoma Unit
Tel: +61 2 9515 7185
Sandie Grierson (Study Coordinator)
Tel: +61 2 9515 6441
Fax: +61 2 9519 6908
Tony Neal (Research Officer)
Tel: +61 2 9519 6560
Fax: +61 2 9519 6908

MSLT 1

PV-10 Chemoablation Study 

Dendritic Cell Vaccine

MSLT 2

Adjuvant Radiotherapy Trial

Interferon ECOG 1697 Trial

Chemosensitivity Study

Ludwig NY-ESO-1 Vaccine